Zhang W, Ding Y, He H, Chen K, Zeng Q, Cao X
Oncol Lett. 2025; 29(4):198.
PMID: 40052067
PMC: 11883337.
DOI: 10.3892/ol.2025.14944.
Charalampopoulou A, Barcellini A, Magro G, Bellini A, Borgna S, Fulgini G
Curr Oncol. 2025; 32(1.
PMID: 39851965
PMC: 11763791.
DOI: 10.3390/curroncol32010049.
Skubal M, Larney B, Phung N, Desmaras J, Dozic A, Volpe A
Theranostics. 2025; 15(3):766-783.
PMID: 39776800
PMC: 11700857.
DOI: 10.7150/thno.95334.
Marco A, Kasparkova J, Bautista D, Kostrhunova H, Cutillas N, Markova L
J Med Chem. 2024; 67(23):21470-21485.
PMID: 39620973
PMC: 11647881.
DOI: 10.1021/acs.jmedchem.4c02357.
Ocampo Y, Caro D, Rivera D, Castro J, Pajaro I, Salas R
Biomed Rep. 2024; 21(6):188.
PMID: 39420920
PMC: 11484217.
DOI: 10.3892/br.2024.1876.
Monolayer culture alters EGFR inhibitor response through abrogation of microRNA-mediated feedback regulation.
Florio A, Johnson S, Salvatori R, Vasmatzis G
Sci Rep. 2024; 14(1):7303.
PMID: 38538642
PMC: 10973516.
DOI: 10.1038/s41598-024-56920-7.
Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation.
Myint K, Balasubramanian B, Venkatraman S, Phimsen S, Sripramote S, Jantra J
Pharmaceuticals (Basel). 2024; 17(2).
PMID: 38399413
PMC: 10892566.
DOI: 10.3390/ph17020197.
Thermosensitive Polymeric Nanoparticles for Drug Co-Encapsulation and Breast Cancer Treatment.
Dartora V, Passos J, Costa-Lotufo L, Lopes L, Panitch A
Pharmaceutics. 2024; 16(2).
PMID: 38399285
PMC: 10892816.
DOI: 10.3390/pharmaceutics16020231.
The role of cell-matrix adhesion and cell migration in breast tumor growth and progression.
Chong L, Yip A, Farm H, Mahmoud L, Zeng Y, Chiam K
Front Cell Dev Biol. 2024; 12:1339251.
PMID: 38374894
PMC: 10875056.
DOI: 10.3389/fcell.2024.1339251.
Advances in screening hyperthermic nanomedicines in 3D tumor models.
Soeiro J, Sousa F, Monteiro M, Gaspar V, Silva N, Mano J
Nanoscale Horiz. 2024; 9(3):334-364.
PMID: 38204336
PMC: 10896258.
DOI: 10.1039/d3nh00305a.
Innovative electrode and chip designs for transendothelial electrical resistance measurements in organs-on-chips.
Holzreuter M, Segerink L
Lab Chip. 2024; 24(5):1121-1134.
PMID: 38165817
PMC: 10898416.
DOI: 10.1039/d3lc00901g.
Insights on Three Dimensional Organoid Studies for Stem Cell Therapy in Regenerative Medicine.
Mulaudzi P, Abrahamse H, Crous A
Stem Cell Rev Rep. 2023; 20(2):509-523.
PMID: 38095787
PMC: 10837234.
DOI: 10.1007/s12015-023-10655-6.
In Vitro Models of Head and Neck Cancer: From Primitive to Most Advanced.
Arutyunyan I, Jumaniyazova E, Makarov A, Fatkhudinov T
J Pers Med. 2023; 13(11).
PMID: 38003890
PMC: 10672510.
DOI: 10.3390/jpm13111575.
Endosomal recycling inhibitors downregulate the androgen receptor and synergise with enzalutamide.
Fletcher K, Alkurashi M, Lindsay A
Invest New Drugs. 2023; 42(1):14-23.
PMID: 37957513
DOI: 10.1007/s10637-023-01407-x.
Ultrasound coupled RES-loaded ultrasound microbubble inhibits the proliferation of ovarian cancer cells by expression of long non-coding RNA (lncRNA) involved in apoptosis using real-time PCR.
Ying H, Ye L
Am J Cancer Res. 2023; 13(9):4434-4445.
PMID: 37818064
PMC: 10560919.
Synergism of small molecules targeting VDAC with sorafenib, regorafenib or lenvatinib on hepatocarcinoma cell proliferation and survival.
Ventura C, Junco M, Santiago Valtierra F, Gooz M, Zhiwei Y, Townsend D
Eur J Pharmacol. 2023; 957:176034.
PMID: 37652292
PMC: 10586475.
DOI: 10.1016/j.ejphar.2023.176034.
Establishment of a 3D Model to Characterize the Radioresponse of Patient-Derived Glioblastoma Cells.
Strand Z, Schrickel F, Dobiasch S, Thomsen A, Steiger K, Gempt J
Cancers (Basel). 2023; 15(16).
PMID: 37627079
PMC: 10452456.
DOI: 10.3390/cancers15164051.
Overview of research progress and application of experimental models of colorectal cancer.
Liu L, Yan Q, Chen Z, Wei X, Li L, Tang D
Front Pharmacol. 2023; 14:1193213.
PMID: 37469864
PMC: 10352992.
DOI: 10.3389/fphar.2023.1193213.
Gell: A GPU-powered 3D hybrid simulator for large-scale multicellular system.
Du J, Zhou Y, Jin L, Sheng K
PLoS One. 2023; 18(7):e0288721.
PMID: 37463167
PMC: 10353785.
DOI: 10.1371/journal.pone.0288721.
Preclinical Models of Neuroblastoma-Current Status and Perspectives.
Krawczyk E, Kitlinska J
Cancers (Basel). 2023; 15(13).
PMID: 37444423
PMC: 10340830.
DOI: 10.3390/cancers15133314.